Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

177Lu-EDTMP: a potential therapeutic bone agent.

A Ando1, I Ando, N Tonami

  • 1School of Health Sciences, Faculty of Medicine, Kanazawa University, Japan.

Nuclear Medicine Communications
|May 11, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adverse Drug Event Profile Associated with Anti-dementia Drugs: Analysis of a Spontaneous Reporting Database.

Die Pharmazie·2023
Same author

Weaning stage hyperglycemia induces glucose-insensitivity in arcuate POMC neurons and hyperphagia in type 2 diabetic GK rats.

Neuropeptides·2018
Same author

Inhibition of malic enzyme 1 disrupts cellular metabolism and leads to vulnerability in cancer cells in glucose-restricted conditions.

Oncogenesis·2017
Same author

Rapid Discrimination of Mitochondrial DNA Type and Use of Results to Study Mitochondrial Inheritance in Pleurotus spp.

Bioscience, biotechnology, and biochemistry·2016
Same author

Synthesis of a Lectin in Both Mycelia and Fruit Bodies of the Ascomycete Mushroom Aleuria aurantia.

Bioscience, biotechnology, and biochemistry·2016
Same author

Purification and Properties of Amylases Extracellularly Produced by an Imperfect Fungus, Fusidium sp. BX-1 in a Glycerol Medium.

Bioscience, biotechnology, and biochemistry·2016
Same journal

Diagnostic performance and quantitative characterization of PET/computed tomography in peritoneal deposits assessment.

Nuclear medicine communications·2026
Same journal

Diagnostic value of dual-time-point 18F-fluorodeoxyglucose PET/computed tomography in differentiating benign and malignant extrahepatic bile duct occupying lesions.

Nuclear medicine communications·2026
Same journal

Prognostic value of baseline 18F- fluroodexoygloucose PET/computed tomography-derived maximum standardized uptake value and tumor bulk in pediatric Hodgkin lymphoma: a retrospective analysis.

Nuclear medicine communications·2026
Same journal

A comparative assessment of [99mTc] HYNIC-PSMA-11 scintigraphy in prostate cancer as a potential substitute for disease evaluation with [68Ga] PSMA-11 PET/CT imaging.

Nuclear medicine communications·2026
Same journal

Prediction of tumor radiation absorbed dose in radionuclide therapy based on the mean standardized uptake value from PET imaging.

Nuclear medicine communications·2026
Same journal

Serum cytokine profiles in papillary thyroid carcinoma patients with lung metastases: characteristics and the relationship with prognosis.

Nuclear medicine communications·2026
See all related articles

Lutetium-177 ethylenediaminetetramethylene phosphonic acid (177Lu-EDTMP) shows high radiochemical yield and stability. This radiopharmaceutical demonstrates selective bone uptake, making it promising for treating bone metastasis pain.

Area of Science:

  • Radiopharmaceutical chemistry
  • Nuclear medicine
  • Oncology

Background:

  • Bone metastases are a common cause of cancer pain.
  • Radiopharmaceuticals are used to palliate pain from bone metastases.
  • Lutetium-177 (177Lu) offers both therapeutic (beta emission) and diagnostic (gamma emission) properties.

Purpose of the Study:

  • To synthesize and evaluate 177Lu-EDTMP as a therapeutic radiopharmaceutical.
  • To assess its potential for palliating pain from bone metastases.

Main Methods:

  • Chelation of 177Lu to EDTMP achieved by heating at pH 8.8.
  • Radiochemical yield and stability assessed.
  • Biodistribution studies conducted in rats, comparing with 99Tcm-MDP.

Related Experiment Videos

Main Results:

  • Radiochemical yield exceeded 99% with high stability for 20 days.
  • Demonstrated selective bone accumulation in rats.
  • Showed faster blood clearance and higher bone uptake than 99Tcm-MDP.
  • Achieved higher bone-to-soft tissue ratios compared to 99Tcm-MDP.

Conclusions:

  • 177Lu-EDTMP possesses favorable biological and physical characteristics.
  • It is a promising candidate for palliative treatment of painful bone metastases.